InsidersTradesSigma
Declaraciones totales
Empresa
▲ Compras (0 oper.)
▼ Ventas (16 oper.)
Historial del iniciado
Director GeneralCompras declaradas
0
Ventas declaradas
16
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the full record of transactions filed by Klee Justin B., Presidente y Director General. Insider active across 1 company, notably Amylyx Pharmaceuticals, Inc.. Cumulatively, 27 disclosures have been published. Breakdown: 0 buy · 16 sells. Total volume traded: €6.1m. History available since 6 January 2022. The latest transaction was disclosed on 18 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Klee Justin B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones27 en total
60.039 títulos0Common StockSEC:0001193125-26-359678:0
248.865 títulos0Common StockSEC:0001193125-26-098437:0
29.282 títulos@ 14,4717 US$4.7% de su flujoCommon StockSEC:0001193125-26-091443:0
15.500 títulos@ 14,685 US$2.5% de su flujoCommon StockSEC:0001193125-26-037544:0
197.153 títulos@ 7,57 US$19.3% de su flujoCommon StockSEC:0001193125-26-017056:0
136.193 títulos@ 13,5827 US$23.9% de su flujoCommon StockSEC:0001193125-26-017056:1
2847 títulos@ 7,57 US$0.3% de su flujoCommon StockSEC:0001193125-26-017056:2
1995 títulos@ 13,8853 US$0.4% de su flujoCommon StockSEC:0001193125-26-017056:3
7715 títulos@ 11,0939 US$1.0% de su flujoCommon StockSEC:0001193125-26-007664:0
29.775 títulos@ 14,3728 US$5.2% de su flujoCommon StockSEC:0001193125-25-228343:0
21.490 títulos@ 3,4646 US$1.0% de su flujoCommon StockSEC:0000950170-25-049495:0
180.118 títulos0Common StockSEC:0000950170-25-036711:0
4595 títulos@ 3,152 US$0.2% de su flujoCommon StockSEC:0000950170-25-033725:0
36.310 títulos@ 1,57 US$0.8% de su flujoCommon StockSEC:0000950170-25-015701:0
11.855 títulos@ 3,4672 US$0.6% de su flujoCommon StockSEC:0000950170-25-014607:0
7471 títulos@ 4,0425 US$0.4% de su flujoCommon StockSEC:0000950170-25-003533:0
63.690 títulos@ 1,57 US$1.4% de su flujoCommon StockSEC:0000950170-24-122640:0
18.589 títulos@ 3,197 US$0.8% de su flujoCommon StockSEC:0000950170-24-111812:0
179.850 títulos0Common StockSEC:0000950170-24-045694:0
4135 títulos@ 18,7279 US$1.1% de su flujoCommon StockSEC:0000950170-24-027922:0
126.667 títulos0Common StockSEC:0000950170-24-022410:0
5841 títulos@ 16,3281 US$1.3% de su flujoCommon StockSEC:0000950170-24-003985:0
96.555 títulos@ 31,8405 US$43.7% de su flujoCommon StockSEC:0000899243-23-009182:0
4122 títulos@ 36,0789 US$2.1% de su flujoCommon StockSEC:0000899243-23-001517:0
1846 títulos@ 36,7888 US$1.0% de su flujoCommon StockSEC:0000899243-23-001517:1
25 de 27 declaraciones
About Klee Justin B.
Klee Justin B. is Président-Directeur Général and Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. He has filed 26 forms in total. Across the 26 sampled filings, all of the sampled filings are disposals, with a total amount of EUR 6077107, over the period from 2022-01-10 to 2026-03-09. Among the main filings are amounts of EUR 2904900.858294359 on 2023-03-20, EUR 1588371.229479196 on 2026-01-20, EUR 1281475.733661938 on 2026-01-20, EUR 364652.0214474811 on 2025-10-02, EUR 360357.2847874585 on 2026-03-04, and EUR 192095.5250615831 on 2026-02-04.
